Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Quetiapine, a second generation antipsychotic, has shown beneficial activity on fibromyalgia
symptomatology, administered as add-on treatment, in a sample of 35 patients. The purpose of
the present study is to compare, in a controlled setting, the efficacy and the tolerability
of quetiapine extended release with amitriptyline in the treatment of patients with
fibromyalgia
Phase:
Phase 4
Details
Lead Sponsor:
Universidad de Granada
Collaborators:
AstraZeneca Hospital Clinico Universitario San Cecilio
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Quetiapine Fumarate